Literature DB >> 23049470

Strategic Point-of-Care Requirements of Hospitals and Public Health for Preparedness in Regions At Risk.

Gerald J Kost1, Pratheep Katip, Corbin M Curtis.   

Abstract

OBJECTIVES: To study health resources and point-of-care (POC) testing requirements for urgent, emergency, and disaster care in Phang Nga Province, Thailand; to determine instrument design specifications through a direct needs assessment survey; to describe POC test menus useful in the small-world network; and to assess strategies for preparedness following the 2004 Tsunami.
METHODS: We surveyed medical professionals in community hospitals, a regional hospital, and the Naval Base Hospital; and officials at the offices of Provincial Public Health and Disaster Prevention and Mitigation. Questions covered: a) demographics and test requirements, b) POC needs, c) device design specifications, and d) pathogen detection options. Respondents scored choices. Scores determined priorities.
RESULTS: Respondents selected complete blood count, electrolytes/chemistry, blood type, oxygen saturation (by pulse oximeter), hematocrit, and microbiology as top priorities, and preferred direct blood sampling with cassettes. Cardiac biomarkers were important in alternate care facilities. Staphylococcus aureus, SARS, Streptococcus pneumoniae, and hepatitis B were top infectious disease problems. Temperature, vibration, humidity, and impact shock were four important environmental conditions during extreme conditions.
CONCLUSIONS: Point-of-care testing can be used on a daily basis for competency and efficiency. Familiarity improves preparedness. Instrument designs must anticipate user preferences and environment stresses. The results show how a region at risk can adapt its small-world network. Point-of-care testing has become an important risk-reducing modality for crises and works equally well in low-resource settings to speed the delivery of routine and urgent care.

Entities:  

Year:  2012        PMID: 23049470      PMCID: PMC3462019          DOI: 10.1097/POC.0b013e31825a2442

Source DB:  PubMed          Journal:  Point Care        ISSN: 1533-029X


  4 in total

1.  Evidence-Based Point-of-Care Device Design for Emergency and Disaster Care.

Authors:  Daniel M Mecozzi; T Keith Brock; Nam K Tran; Kristin N Hale; Gerald J Kost
Journal:  Point Care       Date:  2010-06-01

2.  Evidence-based point-of-care tests and device designs for disaster preparedness.

Authors:  T Keith Brock; Daniel M Mecozzi; Stephanie Sumner; Gerald J Kost
Journal:  Am J Disaster Med       Date:  2010 Sep-Oct

3.  Assessing Point-of-Care Device Specifications and Needs for Pathogen Detection in Emergencies and Disasters.

Authors:  Gerald J Kost; Daniel M Mecozzi; T Keith Brock; Corbin M Curtis
Journal:  Point Care       Date:  2012-06-01

4.  Point-of-care testing for disasters: needs assessment, strategic planning, and future design.

Authors:  Gerald J Kost; Kristin N Hale; T Keith Brock; Richard F Louie; Nicole L Gentile; Tyler K Kitano; Nam K Tran
Journal:  Clin Lab Med       Date:  2009-09       Impact factor: 1.935

  4 in total
  4 in total

Review 1.  The GenePOC Platform, a Rational Solution for Extreme Point-of-Care Testing.

Authors:  Luc Bissonnette; Michel G Bergeron
Journal:  Micromachines (Basel)       Date:  2016-05-24       Impact factor: 2.891

Review 2.  Geospatial Science and Point-of-Care Testing: Creating Solutions for Population Access, Emergencies, Outbreaks, and Disasters.

Authors:  Gerald J Kost
Journal:  Front Public Health       Date:  2019-11-26

Review 3.  Diagnostic Techniques for COVID-19: A Mini-review of Early Diagnostic Methods.

Authors:  Gao-Pan Dong; Xiu-Juan Guo; Ying-Ai Sun; Zheng Zhang; Lu-Pei Du; Min-Yong Li
Journal:  J Anal Test       Date:  2021-10-04

Review 4.  Molecular detection and point-of-care testing in Ebola virus disease and other threats: a new global public health framework to stop outbreaks.

Authors:  Gerald J Kost; William Ferguson; Anh-Thu Truong; Jackie Hoe; Daisy Prom; Arirat Banpavichit; Surin Kongpila
Journal:  Expert Rev Mol Diagn       Date:  2015-09-14       Impact factor: 5.225

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.